💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Athersys, Inc. (ATHX)
« Back to company indexATHX Chatter Timeline
Stock Ticker for ATHX
Most Active Tweeters for ATHX
| User | Tweets |
|---|---|
| @Tickeron | 7 |
| @PennySearch | 6 |
| @petesart | 3 |
| @chrismg88 | 2 |
| @Switterrman | 2 |
Recent Tweets for ATHX
 |
@ATHXLover @EricTopol @jimcramer $athx MultiStem will save your life and they just hired Daniel Camardo as their CEO. January 25th 2022, 5:01pm |
 |
@GeneralOakwood @HardyTSKagimoto $ATHX https://t.co/TvBynFwFh9 January 25th 2022, 4:01am |
 |
@petesart $ATHX indeed. https://t.co/xDMwmVFum4 January 25th 2022, 12:01am |
 |
@chrismg88 $ATHX added some more today. now holding 140K shares January 24th 2022, 6:01pm |
|
@chrismg88 $ATHX $XBI has probably found the bottom with the dip today. Took out the 100 MA on the monthly today. This support… https://t.co/GYoGeN9m48 January 24th 2022, 6:01pm |
 |
@Tickeron $ATHX enters a Downtrend as Momentum Indicator dropped below the 0 level on January 4, 2022. View odds for this and… https://t.co/GQl0CJx0UT January 24th 2022, 8:01am |
 |
@PennySearch $ATHX B of A Securities gave ATHX a Neutral stock rating on 2021-11-19. Find top penny stocks with PennySearch b… https://t.co/Zy9IuNcXxF January 24th 2022, 7:01am |
|
@PennySearch $ATHX B of A Securities gave ATHX a Neutral stock rating on 2021-11-19. Find top penny stocks with PennySearch b… https://t.co/RXMbtbqdbq January 23rd 2022, 1:01am |
|
@Tickeron $ATHX enters a Downtrend because Momentum Indicator dropped below the 0 level on January 4, 2022. View odds for thi… https://t.co/pPfhqY6nGu January 22nd 2022, 8:01am |
|
@PennySearch $ATHX B of A Securities gave ATHX a Neutral stock rating on 2021-11-19. Find top penny stocks with PennySearch b… https://t.co/ZUhSEFq7xv January 22nd 2022, 6:01am |
|
@GeneralOakwood @HardyTSKagimoto Is this true, king? $ATHX https://t.co/CtDQnjz9Ch January 22nd 2022, 2:01am |
 |
@MaisaCorp $ATHX Daniel Camardo has been named as its chief executive officer, effective Feb. 14. January 21st 2022, 10:01pm |
 |
@GetOnTrade $ATHX Athersys Inc. names its new CEO Crains Cleveland Business https://t.co/GVfepdri0W January 21st 2022, 9:01pm |
|
@GetOnTrade $ATHX Health Care Sector Update for 01212022 ALNY RGLS ATHX XLV IBB Nasdaq https://t.co/fzG0Br1HuQ January 21st 2022, 9:01pm |
 |
@Kando_k RT @WallStreetTitan: @athersys Looks like a solid choice to lead $ATHX to commercialization. January 21st 2022, 3:01pm |
|
@Kando_k RT @algobotnews: Athersys appoints Daniel Camardo as CEO $ATHX January 21st 2022, 3:01pm |
 |
@talent4boards Athersys appoints Dan Camardo to #BoardOfDirectors as #CEO @athersys $ATHX https://t.co/p4vhXq1xYe January 21st 2022, 12:01pm |
 |
@EdgarInsider New Form 8-K [Press/News Current Report] entry filed by $ATHX ATHERSYS, INC / NEW https://t.co/mnjOebtCV9 January 21st 2022, 11:01am |
|
@Tickeron $ATHX's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram just turned negative. View odds for th… https://t.co/Ql6jhhDqks January 21st 2022, 8:01am |
 |
@algo_sw @NeuroStockDoc Would be quite funny to see $ATHX skyrocket when so few are expecting it after underperforming for m… https://t.co/c0EojmVNM6 January 21st 2022, 5:01am |
 |
@MarcJacksonLA $ATHX Athersys Appoints Experienced Commercial Leader, Daniel A. Camardo, to Chief Executive Officer - https://t.co/vuLdOmn1qH January 21st 2022, 3:01am |
 |
@WallStreetTitan @athersys Looks like a solid choice to lead $ATHX to commercialization. January 21st 2022, 3:01am |
 |
@bigdaddympg @HardyTSKagimoto When’s the merger? $athx January 21st 2022, 2:01am |
 |
@Athersyss $ATHX #ATHERSYS https://t.co/eqod8rVf7s January 21st 2022, 1:01am |
|
@PennySearch $ATHX B of A Securities gave ATHX a Neutral stock rating on 2021-11-19. Find top penny stocks with PennySearch b… https://t.co/zSvdnM40XO January 21st 2022, 1:01am |
 |
@stockeye1 $ATHX new ceo from horizon pharma January 21st 2022, 12:01am |
 |
@TraderOfStocks1 $ATHX https://t.co/a2v6zt86uh January 21st 2022, 12:01am |
|
@petesart $ATHX "effective Feb 14, 2022" be still my heart. https://t.co/fhc4Aen2Zl January 21st 2022, 12:01am |
 |
@marcus25610498 $ATHX shortly after Jason Few of $FCEL was appointed we went from .30 to 3.00 because of his proven track record of… https://t.co/b57bNNb5mz January 20th 2022, 11:01pm |
 |
@Gambiste1 RT @WebChronicleTo1: $ATHX Athersys Appoints Experienced Commercial Leader, Daniel A. Camardo, to Chief Executive Officer https://t.co/OE… January 20th 2022, 11:01pm |
 |
@MarketCurrents $ATHX - Athersys appoints veteran Daniel A. Camardo, to CEO post https://t.co/1BcaYHg0CZ January 20th 2022, 11:01pm |
 |
@vtmtrading Athersys appoints Daniel Camardo as CEO $ATHX January 20th 2022, 11:01pm |
 |
@phasefivebot $ATHX Athersys Appoints Experienced Commercial Leader, Daniel A. Camardo, to Chief Executive Officer https://t.co/StlisFhL3G January 20th 2022, 11:01pm |
 |
@otcdynamics $ATHX Athersys Appoints Experienced Commercial Leader, Daniel A. Camardo, to Chief Executive Officer https://t.co/csj8rfqlUJ January 20th 2022, 11:01pm |
 |
@NeuroStockDoc $ATHX Appoints CEO with extensive experience launching new drugs. I think this must mean the data is good. I’ll be… https://t.co/Pek95RVq2T January 20th 2022, 11:01pm |
 |
@StckPro $ATHX NEW ARTICLE : Athersys Appoints Experienced Commercial Leader, Daniel A. Camardo, to Chief Executive Officer… https://t.co/ekbxHHlwFE January 20th 2022, 11:01pm |
 |
@newsfilterio Athersys Appoints Experienced Commercial Leader, Daniel A. Camardo, to Chief Executive Officer $ATHX https://t.co/gIEg3YNCux January 20th 2022, 11:01pm |
 |
@StockNewsBot2 $ATHX Athersys Appoints Experienced Commercial Leader, Daniel A. Camardo, to Chief Executive Officer https://t.co/ia11uc9F9q January 20th 2022, 11:01pm |
 |
@stock_titan $ATHX Athersys Appoints Experienced Commercial Leader, Daniel A. Camardo, to Chief Executive Officer https://t.co/bpsogbkRr5 January 20th 2022, 11:01pm |
 |
@WebChronicleTo1 $ATHX Athersys Appoints Experienced Commercial Leader, Daniel A. Camardo, to Chief Executive Officer https://t.co/OE3adt7eL0 January 20th 2022, 11:01pm |
|
@Tickeron $ATHX's Aroon indicator drops into Downtrend on January 14, 2022. View odds for this and other indicators:… https://t.co/9JHU0JAr9r January 20th 2022, 10:01pm |
 |
@RuiLobo11 RT @SeekingAlpha: $ATHX - Athersys: Near-Term Progress In Stem Cell Phase 3 Trials Could Multiply Shares In 2022. https://t.co/wTLuY1PhMl #… January 20th 2022, 9:01pm |
 |
@Formercare From Seeking Alpha: $ATHX - Athersys: Near-Term Progress In Stem Cell Phase 3 Trials Could Multiply Shares In 2022 https://t.co/INQYZ6Yf06 January 20th 2022, 7:01pm |
 |
@Beeken_health $ATHX - Athersys: Near-Term Progress In Stem Cell Phase 3 Trials Could Multiply Shares In 2022… https://t.co/LCkB0Lf1Mg January 20th 2022, 7:01pm |
 |
@SeekingAlpha $ATHX - Athersys: Near-Term Progress In Stem Cell Phase 3 Trials Could Multiply Shares In 2022.… https://t.co/xlP3iXjZ0n January 20th 2022, 7:01pm |
 |
@3crescentmoons So….When will you be done with MASTERS-2? It started in 2018! $ATHX #ATHXFacts https://t.co/8PfLkLKOrd January 19th 2022, 2:01pm |
|
@Tickeron $ATHX's Aroon indicator drops into Downtrend on January 14, 2022. View odds for this and other indicators:… https://t.co/08LIewWqI3 January 18th 2022, 6:01pm |
|
@PennySearch $ATHX B of A Securities gave ATHX a Neutral stock rating on 2021-11-19. Find top penny stocks with PennySearch b… https://t.co/hGsMdONek4 January 18th 2022, 12:01pm |
 |
@Switterrman RT @AlexSalfetnikov: can't believe how much I left on the table with $ATHX January 17th 2022, 6:01pm |
|
@Switterrman RT @AlexSalfetnikov: $863 profit on $ATHX first red day. Missed the bottom I thought support would hold but can't complain @timothysykes ht… January 17th 2022, 6:01pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2022. All rights reserved.
DrugPatentWatch Video Training
Decision-making for generic drug entry and branded drug lifecycle management
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
This course answers the following questions to help you adapt:
- ✓ When will key drug patents expire?
- ✓ How can I find, evaluate, and plan for generic market entry opportunities?
- ✓ How can I find proprietary out-of-court settlements and deal terms?